Ovotesticular disorder of sex development, historically called “true hermaphroditism,” is the rarest form of all disorders of sex development (DSD) in humans, defined by the presence of both ovarian and testicular tissue in the same person.1PubMed Central. Ovotesticular Disorder of Sex Development: An Unusual Presentation Unlike the many fish species that routinely change sex or carry both tissue types at once, this condition in humans arises from unusual genetic events during early development and presents a genuine clinical challenge. The genetics behind it are more varied than most people assume, the path to diagnosis often takes years, and fertility, while rare, is not impossible.
Why the Name Changed
The term “true hermaphrodite” was used in medical literature for more than a century, but clinicians and advocacy groups moved away from it in the mid-2000s. The 2006 Chicago Consensus on DSD classification replaced it with “ovotesticular DSD” (sometimes abbreviated OT-DSD). The shift happened partly because “hermaphrodite” carried stigma and was widely misunderstood by the public, and partly because the older label conflated a specific human condition with the normal reproductive biology of organisms that are genuinely hermaphroditic by design. In current medical practice you will still see the old term in older case reports and textbooks, but any paper published after roughly 2006 uses the newer terminology.
The Genetic Landscape
One of the most surprising things about ovotesticular DSD is that most affected individuals have a standard 46,XX karyotype, the same chromosome complement typically associated with female development. In a Korean series of 14 patients with the condition, 46,XX accounted for about 71% of cases, while a mosaic pattern (45,X/46,XY) accounted for about 21%, and chimerism (46,XX/46,XY) made up the remaining fraction.2PubMed Central. Pubertal outcomes and sex of rearing of patients with ovotesticular disorder of sex development and mixed gonadal dysgenesis A separate single-center study found a similar skew, with six of seven patients carrying a 46,XX karyotype and one carrying 46,XY.3Endocrine Practice. Ovotesticular Disorder of Sex Development: A Single-Center Experience The dominance of 46,XX cases is consistent across most populations studied, though there are geographic exceptions discussed further below.
The question that naturally follows is: how does someone with no Y chromosome develop testicular tissue? In typical male development, a gene on the Y chromosome called SRY triggers a cascade that directs the undifferentiated gonad to become a testis. In 46,XX ovotesticular DSD, SRY is usually absent. Instead, other genetic changes can activate the testicular pathway. One well-documented mechanism involves the gene SOX9, which sits downstream of SRY in the sex-determination cascade. A case report identified a large duplication in the chromosomal region containing SOX9, and this extra copy was enough to drive testicular tissue formation even without SRY.4PubMed Central. A Duplication Upstream of SOX9 Associated with SRY Negative 46,XX Ovotesticular Disorder of Sex Development Other reported mechanisms include translocated fragments of the Y chromosome that carry SRY but are too small to show up on a standard karyotype, and mutations in regulatory regions that alter dosage of key sex-determination genes.
The upshot is that ovotesticular DSD is not one genetic event. It is a clinical endpoint that several different genetic paths can reach, which is part of why it was so poorly understood for decades.
What the Gonads Actually Look Like
The defining feature of ovotesticular DSD is the gonad itself. A person might have an ovotestis on one side and an ovary or testis on the other, or ovotestes on both sides. In a study of 111 South African patients, pathologists described two broad categories of ovotestis based on how the ovarian and testicular tissues were arranged.5PubMed. The gonads of 111 South African patients with ovotesticular disorder of sex differentiation
- Mixed type: Found in about 89% of ovotestes. These have an outer shell of ovarian tissue surrounding an inner core that contains both tissue types in varying degrees of intermingling. Some had scattered islands of testicular and ovarian tissue mixed together, while others had a thickened ovarian cap at one end and a concentrated mass of testicular tissue at the other.
- Bipolar type: Found in about 11%. Here the ovarian and testicular halves occupy distinct poles of the gonad, separated by an irregular boundary where the two tissue types interlock.
This internal architecture matters clinically because it determines whether surgeons can separate functional tissue during gonad-sparing operations, and it affects both the hormonal output and the fertility potential of the gonad.
How People Present Clinically
Most people imagine that ovotesticular DSD always shows up at birth as ambiguous genitalia. That is the most common presentation, but it is not the only one. Fetal sex development happens in stages: first, the undifferentiated structures form identically in all embryos; then the gonads differentiate into ovaries or testes; and finally, the internal and external genitalia develop under the influence of whatever hormones those gonads produce.6PubMed. Normal male sexual differentiation and aetiology of disorders of sex development In ovotesticular DSD, because both types of gonadal tissue coexist, the hormonal signals are mixed, and the resulting anatomy falls along a wide spectrum.
Some individuals look outwardly male at birth and are raised as boys, with the condition discovered only much later. A case report describes a 15-year-old who appeared phenotypically male with normal external genitalia but developed progressive breast enlargement over two years. Examination revealed one undescended testis, and further workup confirmed ovotesticular DSD.7PubMed. Ovotesticular disorder of sex development presenting as gynecomastia in a phenotypic male adolescent The breast growth was driven by estrogen produced by the ovarian component of the gonad, a signal that did not become clinically obvious until puberty ramped up hormonal activity. Cases like this illustrate that ovotesticular DSD can hide in plain sight for years, and that unexplained breast development or menstrual bleeding in someone raised male should prompt evaluation.
Diagnosis and Imaging
Confirming ovotesticular DSD ultimately requires demonstrating both ovarian and testicular tissue, which means a tissue sample examined under a microscope. But imaging plays an important role in guiding clinicians toward the right diagnosis and planning surgery. MRI of the abdomen and pelvis can reveal structures that shouldn’t coexist in either a typical male or typical female body. In one reported case, contrast-enhanced MRI showed an undescended testis on the left side near the bladder and a structure resembling a fallopian tube with an ovary on the right. The scan also identified a remnant of the Müllerian duct, the embryonic tube that normally develops into the uterus and fallopian tubes in females but regresses in typical male development. Both gonads showed restricted diffusion on specialized imaging sequences, raising concern for abnormal cellularity that turned out to warrant surgical removal.8Iranian Journal of Radiology. Magnetic Resonance Imaging Findings of Ovotesticular Disorder of Sex Development with Bilateral Gonadoblastoma
The diagnostic workup typically also includes hormone levels (testosterone, estrogen, anti-Müllerian hormone), chromosomal analysis, and sometimes molecular genetic testing to look for hidden Y-chromosome material or gene duplications. None of these tests alone clinches the diagnosis; they collectively point the clinical team toward the gonadal biopsy or surgical exploration that provides the definitive answer. Because the condition is so rare, misdiagnosis or delayed diagnosis is common, especially outside specialized DSD centers.
Gonadal Tumor Risk
One of the first questions families and patients have is whether the abnormal gonadal tissue raises cancer risk. Compared to some other DSDs, ovotesticular DSD carries a relatively low risk of gonadal tumors, with reported rates around 2.5–4%.9PubMed Central. Endocrine Management of Ovotesticular DSD, an Index Case and Review of the Literature Those low numbers probably reflect the fact that the majority of affected individuals have a 46,XX karyotype and lack SRY. The risk is not uniform, though. It shifts upward in people who carry Y-chromosome material, who have an undescended gonad sitting inside the abdomen, or whose tissue appears poorly differentiated or dysgenetic on biopsy. An intra-abdominal streak gonad in someone with Y-chromosome material is the highest-risk scenario and typically warrants removal. By contrast, a descended gonad in someone raised male may carry considerably less risk even if Y-chromosome material is present.9PubMed Central. Endocrine Management of Ovotesticular DSD, an Index Case and Review of the Literature
Gonadal biopsy at the time of diagnosis helps stratify this risk. Pathologists look for precursor lesions, and the degree of tissue differentiation informs the decision about whether to remove a gonad entirely or attempt a tissue-sparing approach.
Surgical Management and the Shift Toward Gonad-Sparing Approaches
For decades, the standard surgical approach was to remove the gonadal tissue that didn’t match the sex of rearing. If a child was raised female, testicular tissue was taken out; if raised male, ovarian tissue was removed. More recently, the field has moved toward gonad-sparing procedures whenever anatomy allows. This is especially favored in 46,XX patients raised as female, because preserving ovarian tissue maintains hormonal function and the possibility of future fertility.10PubMed. Laparoscopic gonad-sparing procedure in Ovotesticular disorder of sex development – Case video technique Laparoscopic techniques make it possible to dissect out unwanted tissue while keeping the functioning portion intact. In a French series of patients with SRY-negative 46,XX testicular or ovotesticular DSD, gonadal surgery preserved appropriate tissue in the majority of cases.11PubMed. SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis Even so, long-term monitoring for tumor development remains necessary after any gonad-sparing operation.
The timing of surgery has also become more contentious. Current clinical guidelines increasingly recommend deferring cosmetic genital procedures that are not medically urgent until the patient is old enough to participate in decision-making. A case report involving a patient who had clitoroplasty and vaginoplasty performed in early childhood noted that while the patient did not express dissatisfaction later, the authors believed deferring would have been the better course, in line with newer guidelines that reserve non-urgent procedures for adolescence or adulthood when the patient can provide informed input.12PubMed Central. Gender Dysphoria in a Patient With Ovotesticular Disorder of Sex Development This ethical shift reflects growing recognition that early irreversible surgery can have lasting consequences for body image, sexual function, and gender identity.
Reproduction in Ovotesticular DSD
Fertility is rare across the full spectrum of ovotesticular DSD, as it is in most complex disorders of sex development.13PubMed. Fertility in disorders of sex development: A review But “rare” is not “never,” and the handful of documented pregnancies is one of the more striking aspects of this condition. For the ovarian side, functioning ovarian tissue can sometimes produce mature eggs, and if a uterus is present and structurally adequate, pregnancy becomes at least theoretically possible. On the testicular side, mature sperm production is extremely uncommon; the testicular tissue in ovotesticular DSD tends to be poorly organized, and the mixed hormonal environment is inhospitable to spermatogenesis.
The most detailed recent pregnancy report involved a 29-year-old woman with a 46,XX karyotype who had undergone removal of one gonad at age six and reconstructive surgery on the vulva and vagina in childhood. Her remaining gonad and uterus were normal, and spontaneous ovulation was confirmed. However, sexual intercourse was not possible due to pain from a narrowed vagina after previous surgery, and five cycles of artificial insemination failed. In vitro fertilization ultimately succeeded, and she delivered a healthy male infant at 37 weeks by cesarean section.14Journal of Nippon Medical School. Successful in Vitro Fertilization Pregnancy and Delivery by an Infertile Woman with Ovotesticular Disorder of Sex Development That case was reported as only the eighth documented live birth from a person with ovotesticular DSD who had undergone gonadectomy, and the first achieved through IVF. The number underscores how unusual pregnancy is in this population, but it also demonstrates that assisted reproduction can offer a realistic option for some individuals, particularly those with a 46,XX karyotype, a functional ovary, and an intact uterus.
For individuals raised male, the prospects for biological fatherhood are much dimmer. The testicular tissue in ovotesticular DSD rarely produces enough viable sperm to achieve fertilization, and the hormonal milieu created by coexisting ovarian tissue further suppresses spermatogenesis. No well-documented case of paternity has been reported in the medical literature.
Geographic and Ethnic Variation
The distribution of karyotypes in ovotesticular DSD is not the same everywhere. While 46,XX predominates in most studied populations, Japanese data tell a different story: in Japanese cohorts, the frequency of testicular tissue was higher than in other ethnic groups, and this was linked to a higher incidence of 46,XY karyotypes.15Wiley Online Library. Long-term outcome of ovotesticular disorder of sex development: a single center experience Southern Africa, by contrast, has historically reported a disproportionately high number of cases overall, many of them 46,XX. Whether these geographic patterns reflect genuinely different genetic predispositions, differences in ascertainment and referral patterns, or some combination is still debated. The condition is rare enough globally that even the largest series involve dozens of patients rather than hundreds, making firm epidemiological conclusions difficult.
How Ovotesticular DSD Differs From Hermaphroditism in Other Species
People sometimes assume that ovotesticular DSD in humans is similar to the hermaphroditism seen in fish, snails, or certain plants. The mechanisms are fundamentally different. In many teleost fish species, hermaphroditism is a normal, regulated reproductive strategy that can take several forms: some species are simultaneously male and female, others change from female to male or vice versa at particular life stages, and some can switch direction depending on social conditions.16Oxford Academic (Integrative and Comparative Biology). Phylogenetic Perspectives on the Evolution of Functional Hermaphroditism in Teleost Fishes These transitions are driven by evolved genetic programs tied to mating systems and environmental cues. They are adaptive, reversible in some cases, and produce fully functional reproductive tissue appropriate to each role.
Human ovotesticular DSD, by contrast, results from a disruption in a developmental pathway that is normally committed to one sex or the other very early in embryonic life. The coexistence of both tissue types is not part of a programmed strategy, and the tissues do not typically reach full functional maturity on both sides. Drawing parallels between clownfish changing sex on a reef and a human child with mixed gonadal tissue misunderstands both phenomena. The fish has a system designed to do exactly what it is doing; the human has a system that went down two paths at once due to an unusual genetic event.
Living With the Diagnosis
Beyond the medical management, ovotesticular DSD raises questions that are less about biology and more about identity. Sex assignment at birth, which for most infants is straightforward, becomes a complex decision involving endocrinologists, surgeons, geneticists, psychologists, and the family. The older practice was to assign sex early and operate to make the anatomy match that assignment, often before the child could have any say. The current trend, backed by evolving clinical consensus, favors minimizing irreversible interventions in infancy and providing psychological support as the child grows.12PubMed Central. Gender Dysphoria in a Patient With Ovotesticular Disorder of Sex Development
Gender identity in people with ovotesticular DSD does not always align with the sex assigned at birth, just as in the broader DSD population. Case reports document individuals who later identify with a gender different from their rearing, and the psychological toll of early surgery that cannot be undone is a growing concern in the DSD community. Access to peer support, mental health professionals with DSD expertise, and accurate medical information all contribute to better long-term outcomes. For families navigating a new diagnosis, connecting with a multidisciplinary DSD team at a specialized center is the single most impactful step, because the decisions made in the first years of life can shape a person’s physical and psychological trajectory for decades.